Antiangogenic effect of selected phytochemicals

Pharmazie

Volumn 65, Issue 1, 2010, Pages 57-63

  Varinska, L ^a   Mirossay, L ^a   Mojzisova, G ^a   Mojzis, J ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLIIN; BERBERINE; CURCUMIN; CURCUMIN 3; DEMETHOXYCURCUMIN; DIALLYL TRISULFIDE; EMODIN; GARLIC EXTRACT; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 2; GINSENOSIDE RG 3; HYDRAZINOCURCUMIN; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; PLANT MEDICINAL PRODUCT; RESVERATROL; SALICYL CURCUMIN; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANXIETY DISORDER; CONCENTRATION RESPONSE; COPTIS; DEPRESSION; GARLIC; GINSENG; GLIOMA; HUMAN; HYPERICUM PERFORATUM; IC 50; LEWIS CARCINOMA; LIVER CELL CARCINOMA; LUNG METASTASIS; NONHUMAN; REVIEW; RHUBARB;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CURCUMIN; HUMANS; PLANTS; STILBENES;

EID: 76149113599     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9667     Document Type: Review

References (84)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783-2840.
2. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398.
3. Agostinis P, Vantieghem A, Merlevede W, de Witte PA (2002) Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 34: 221-241.
4. Bae MK, Kim SH, Jeong JW, Lee YM, Kim HS, Kim SR, Yun I, Bae SK, Kim KW (2006) Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol Rep 15: 1557-1562.
5. Beecken WD, Fernandez A, Panigrahy D, Achilles EG, Kisker O, Flynn E, Joussen AM, Folkman J, Shing Y (2000) Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice. Urology 56: 521-526.
6. Belleri M, Ribatti D, Savio M, Stivala LA, Forti L, Tanghetti E, Alessi P, Coltrini D, Bugatti A, Mitola S, Nicoli S, Vannini V, Presta M (2008) alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. Mol Cancer Ther 7: 3761-3770.
7. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nature Rev Cancer 3: 401-410.
8. Brem H, Gresser I, Grosfeld J, Folkman J (1993) The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 28: 1253-1257.
9. Cao Y, Fu ZD, Wang F, Liu HY, Han R (2005) Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res 7: 205-213.
10. Cao Z, Fang J, Xia C, Shi X, Jiang BH (2004) trans-3,4,5′- Trihydroxystibene inhibits hypoxia-inducible factor 1α and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 10: 5253-5263.
11. Coultas L, Chawengsaksophak K, Rossant J (2005) Endothelial cells and VEGF in vascular development. Nature 438: 937-945.
12. Cox MC, Dahut WL, Figg WD (2006) The use of thalidomide in androgen-independent prostate cancer. Urol Oncol 24: 246-249.
13. Dannenberg AJ, Subbaramaiah K (2003) Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 4: 431-436.
14. Dell'aica I, Niero R, Piazza F, Cabrelle A, Sartor L, Colalto C, Brunetta E, Lorusso G, Benelli R, Albini A, Calabrese F, Agostini C, Garbisa S (2007) Hyperforin blocks neutrophil activation of MMP-9, motility and recruitment,and restrains inflammation-triggered angiogenesis and lung fibrosis. J Pharmacol Exp Ther 321: 492-500.
15. Eder JP, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DW (2002) Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol 20: 3772-3784.
16. Folkman J (1995) Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763.
17. Fuggetta MP, Lanzilli G, Tricarico M, Cottarelli A, Falchetti R, Ravagnan G, Bonmassar E (2006) Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. J Exp Clin Cancer Res 25: 189-193.
18. Fujita Y, Abe R, Shimizu H (2008) Clinical approaches toward tumor angiogenesis: past, present and future. Curr Pharm Des 14: 3820-3834.
19. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H (1999a) Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 66: 227-233.
20. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H (1999b) Inhibition of activator protein 1 by berberine in human hepatoma cells. Planta Med 65: 381-383.
21. Gururaj AE, Belakavadi M, Venkatesh DA, Marme D, Salimath BP (2002) Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 297: 934-942.
22. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
23. Hendrickx N, Dewaele M, Buytaert E, Marsboom G, Janssens S, Van Boven M, Vandenheede JR, de Witte P, Agostinis P (2005) Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy. Biochem Biophys Res Commun 337: 928-935.
24. Huang HC, Lee CR, Chao PD, Chen CC, Chu SH (1991)Vasorelaxant effect of emodin, an anthraquinone from a Chinese herb. Eur J Pharmacol 205: 289-294.
25. Huang Q, Shen HM, Ong CN (2004) Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem Pharmacol 68: 361-371.
26. Chen JC, Chen Y, Lin JH, Wu JM, Tseng SH (2006) Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound. Anticancer Res 26: 1237-1245.
27. Chen MW, Ni L, Zhao XG, Niu XY (2005) The inhibition of 20(R)-ginsenoside Rg3 on the expressions of angiogenesis factors proteins in human lung adenocarcinoma cell line A549 and HUVEC304 cell. Zhongguo Zhong Yao Za Zhi 30: 357-360. (in Chinese).
28. Choi H, Chun YS, Kim SW, Kim MS, Park JW (2006) Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol Pharmacol 70: 1664-1671.
29. Igura K, Ohta T, Kuroda Y, Kaji K (2001) Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171: 11-16.
30. Kanaoka S,Takai T, Yoshida K (2007) Cyclooxygenase-2 and tumor biology. Adv Clin Chem 43: 59-78.
31. Kaneshiro T, Morioka T, Inamine M, Kinjo T, Arakaki J, Chiba I, Sunagawa N, Suzui M, Yoshimi N (2006) Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. Eur J Pharmacol 553: 46-53.
32. Khan SA, Priyamvada S, Farooq N, Khan S, Khan MK, Yusufi ANK (2009) Protective effect of green tea extract on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Pharmacol Res 2009; 59:254-62.
33. Khanum F, Anilakumar KR, Viswanathan KR (2004) Anticarcinogenic properties of garlic: a review. Crit Rev Food Sci Nutr 44: 479-488.
34. Kiesslich T, Krammer B, Plaetzer K (2006) Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem 13: 2189-2204.
35. Kim JH, Shim JS, Lee SK, Kim KW, Rha SY, Chung HC, Kwon HJ (2002) Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Jpn J Cancer Res 93: 1378-1385.
36. Kimura Y, Okuda H (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131:1844-1849.
37. Kimura Y, Sumiyoshi M, Baba K (2008) Antitumor activities of synthetic and natural stilbenes through antiangiogenic action. Cancer Sci 99: 2083-2096.
38. Kulke, MH, Stuart K, Enzinger PC, Ryan DP, Clark JW, Muzikansky M, Vincitore M, Michelini A, Fuchs CS (2006) Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol 24: 401-406.
39. Kwak HJ, Park MJ, Park CM, Moon SI, Yoo DH, Lee HC, Lee SH, Kim MS, Lee HW, Shin WS, Park IC, Rhee CH, Hong SI (2006) Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer 118: 2711-2720.
40. Lavie G, Mandel M, Hazan S, Barliya T, Blank M, Grunbaum A, Meruelo D, Solomon A (2005) Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications. Angiogenesis 8: 35-42.
41. Lee HS, Jung KK, Cho JY, Rhee MH, Hong S, Kwon M, Kim SH, Kang SY (2007) Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activation. Pharmazie 62: 937-942.
42. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY (2007) Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 56:193-201.
43. Lev-Ari S, Maimon Y, Strier L, Kazanov D, Arber N (2006) Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines. J Soc Integr Oncol 4: 21-26.
44. Leyon PV, Kuttan G (2003) Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J Exp Clin Cancer Res 22: 77-83.
45. Lin MT, Yen ML, Lin CY, Kuo ML (2003) Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 64: 1029-1036.
46. Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG (2004) Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol 66: 612-619.
47. Lu Y, Zhang J, Qian J (2008) The effect of emodin on VEGF receptors in human colon cancer cells.Cancer Biother Radiopharm 23: 222-228.
48. Magrone T, Candore G, Caruso C, Jirillo E, Covelli V (2008) Polyphenols from red wine modulate immune responsiveness: biological and clinical significance. Curr Pharm Des 14: 2733-2748.
49. Mahady GB, Gyllenhall C, Fong HH, Farnsworth NR (2000) Ginsengs: a review of safety and efficacy. Nutr Clin Care 3: 90-101.
50. Martinez-Poveda B, Quesada AR, Medina MA (2005) Hyperforin, a bioactive compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process. Int J Cancer 117: 775-780.
51. Matsuura N, Miyamae Y, Yamane K, Nagao Y, Hamada Y, Kawaguchi N, Katsuki T, Hirata K, Sumi S, Ishikawa H (2006) Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr 136: 842S-846S.
52. Maulik N (2002) Redox signaling of angiogenesis. Antioxid Redox Signal 2002: 805-815.
53. Milner JA (2001) Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv Exp Med Biol 492: 69-81.
54. Mirossay L, Mirossay A, Kocisova E, Radvakova I, Miskovsky P, Mojzis J (1999) Hypericin-induced phototoxicity of human leukemic cell line HL-60 is potentiated by omeprazole, an inhibitor of H+K+-ATPase and 5′-(N,N- dimethyl)-amiloride, an inhibitor of Na+/H+ exchanger. Physiol Res 48: 135-141.
55. Mojzis J, Varinska L, Mojzisova G, Kostova I, Mirossay L (2008) Antiangiogenic effects of flavonoids and chalcones. Pharmacol Res 57: 259-265.
56. Mousa AS, Mousa SA (2005) Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53. Nutr Cancer 53: 104-110.
57. Mousa SS, Mousa SS, Mousa SA (2005) Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model. Nutr Cancer 52: 59-65.
58. Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, Capaccioli S (2009) Natural compounds for cancer treatment and prevention. Pharmacol Res 59: 365-78.
59. Pan MH, Ho CT (2008) Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 37: 2558-2574.
60. Park SY, Jeong KJ, Lee J, Yoon DS, Choi WS, Kim YK, Han JW, Kim YM, Kim BK, Lee HY (2007) Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. Cancer Lett 258: 63-69.
61. Quiney C, Billard C, Mirshahi P, Fourneron JD, Kolb JP (2006) Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells. Leukemia 20: 583-589.
62. Roscetti G, Franzese O, Comandini A, Bonmassar E (2004) Cytotoxic activity of Hypericum perforatum L. on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin. Phytother Res 18: 66-72.
63. Sackova V, Kulikova L, Mikes J, Kleban J, Fedorocko P (2005) Hypericin-mediated photocytotoxic effect on HT-29 adenocarcinoma cells is reduced by light fractionation with longer dark pause between two unequal light doses. Photochem Photobiol 81: 1411-1416.
64. Sarissky M, Lavicka J, Kocanova S, Sulla I, Mirossay A, Miskovsky P, Gajdos M, Mojzis J, Mirossay L (2005) Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells. Neoplasma 52: 352-359.
65. Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I (1994) Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull 17: 635-639.
66. Shih T, Lindley C (2006) Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28: 1779-1802.
67. Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee SK, Kim KW, Ahn JW, Yoo JS, Rho JR, Shin J, Kwon HJ (2002) Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation. Bioorg Med Chem 10: 2987-2992.
68. Shim JS, Kim JH, Cho HY, Yum YN, Kim SH, Park HJ, Shim BS, Choi SH, Kwon HJ (2003) Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem Biol 10: 695-704.
69. Schempp CM, Kiss J, Kirkin V, Averbeck M, Simon-Haarhaus B, Kremer B, Termeer CC, Sleeman J, Simon JC (2005) Hyperforin acts as an angiogenesis inhibitor. Planta Med 71: 999-1004.
70. Singh AK, Sidhu GS, Deepa T, Maheshwari RK (1996) Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett 107: 109-115.
71. Singh S, Khar A (2006) Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 6: 259-270.
72. Stupakova V, Varinska L, Mirossay A, Sarissky M, Mojzis J, Dankovcík R, Urdzik P, Ostro A, Mirossay L (2009) Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines. Phytother Res 23: 827-832.
73. Su CC, Chen GW, Lin JG, Wu LT, Chung JG (2006) Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res 26: 1281-1288.
74. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK (1998) Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9: 305-312.
75. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, Lin PY, Chen Y (2004) Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10: 2190-2202.
76. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716.
77. Woo HB, Shin WS, Lee S, Ahn CM (2005) Synthesis of novel curcumin mimics with asymmetrical units and their anti-angiogenic activity. Bioorg Med Chem Lett 15: 3782-3786.
78. Xiao D, Li M, Herman-Antosiewicz A, Antosiewicz J, Xiao H, Lew KL, Zeng Y, Marynowski SW, Singh SV (2006) Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2. Nutr Cancer 55: 94-107.
79. Yee KK, Soo KC, Olivo M (2005) Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. Int J Mol Med 16: 993-1002.
80. Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S (2006) Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc 34: 109-115.
81. Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S (2008) Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice.World J Gastroenterol 14: 2003-2009.
82. Yue PY, Wong DY, Wu PK, Leung PY, Mak NK, Yeung HW, Liu L, Cai Z, Jiang ZH, Fan TP, Wong RN (2006) The angiosuppressive effects of 20(R)- ginsenoside Rg3. Biochem Pharmacol 72: 437-445.
83. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD (2005) Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1α and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 4: 1465-1474.
84. Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q (2005) Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 11: 280-284.